Norihiro Hanabata

Delayed and multisystem immune-related adverse events in MSI-high colon cancer treated with nivolumab plus ipilimumab

Abstract Immune checkpoint inhibitors (ICIs) can cause immune-related adverse events (irAEs) involving multiple organs. However, delayed-onset, multisystem irAEs after treatment discontinuation are uncommon. Here, we present a rare case of a man in his 50s with microsatellite ins...